EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Syneos Health's enterprise value is $10,072 Mil.
Syneos Health's EBITDA for the trailing twelve months (TTM) ended in Jun. 2022 was $685 Mil. Therefore, Syneos Health's EV-to-EBITDA for today is 14.71.
The historical rank and industry rank for Syneos Health's EV-to-EBITDA or its related term are showing as below:
SYNH'
s EV-to-EBITDA Range Over the Past 10 Years
Min: 12.18 Med: 19.07 Max: 80.28
Current: 14.9
During the past 11 years, the highest EV-to-EBITDA of Syneos Health was 80.28. The lowest was 12.18. And the median was 19.07.
SYNH's EV-to-EBITDA is ranked worse than 55.15% of 136
companies
in the Medical Diagnostics & Research industry
Industry Median: 13.32
vs SYNH: 14.90
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
As of today (2022-08-16), Syneos Health's stock price is $69.99.
Syneos Health's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2022 was $2.660. Therefore, Syneos Health's PE Ratio for today is 26.31.
The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.
Syneos Health EV-to-EBITDA Historical Data
The historical data trend for Syneos Health's EV-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Premium members only.
Syneos Health Annual Data
Trend
Dec12
Dec13
Dec14
Dec15
Dec16
Dec17
Dec18
Dec19
Dec20
Dec21
EV-to-EBITDA
54.94
14.60
18.85
19.38
21.63
Syneos Health Quarterly Data
Sep17
Dec17
Mar18
Jun18
Sep18
Dec18
Mar19
Jun19
Sep19
Dec19
Mar20
Jun20
Sep20
Dec20
Mar21
Jun21
Sep21
Dec21
Mar22
Jun22
EV-to-EBITDA
21.45
20.34
21.63
17.99
15.12
Competitive Comparison
For the Diagnostics & Research subindustry, Syneos Health's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Syneos Health EV-to-EBITDA Distribution
For the Medical Diagnostics & Research industry and Healthcare sector, Syneos Health's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Syneos Health's EV-to-EBITDA falls into.
Syneos Health EV-to-EBITDA Calculation
Syneos Health's EV-to-EBITDA for today is calculated as:
Syneos Health's current Enterprise Value is $10,072 Mil.
Syneos Health's EBITDA for the trailing twelve months (TTM) ended in Jun. 2022 adds up the quarterly data reported by the company within the most recent 12 months, which was $685 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Syneos Health (NAS:SYNH) EV-to-EBITDA Explanation
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
Syneos Health's PE Ratio for today is calculated as:
Syneos Health's share price for today is $69.99.
Syneos Health's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2022 adds up the quarterly data reported by the company within the most recent 12 months, which was $2.660.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.
Thank you for viewing the detailed overview of Syneos Health's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.
Syneos is a global contract research and outsourced commercialization organization that provides services to pharmaceutical and biotechnology firms. Its clinical solutions segment offers early- to late-stage clinical trial support that ranges from specialized staffing models to strategic partnerships that oversee nearly all aspects of a drug program, while the company's commercialization solutions includes outsourced sales, consulting, public relations, and advertising services.
My Portfolios
Create New Portfolio
Portfolio Contest
My Gurus
Personalize
Premium Gurus 
1.11(1.61%) Volume: 503,403 11:08PM EDT
Email Alerts
Stock PDF
RSS
Website
Filings
Download
Manual of Stocks™ Web APP
NAS:SYNH has been successfully added to your 
